Working… Menu

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04371978
Recruitment Status : Terminated (End of COVID-19 outbreak in Israel)
First Posted : May 1, 2020
Last Update Posted : June 2, 2021
Information provided by (Responsible Party):
Ran Abuhasira, Rabin Medical Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 4, 2021
Actual Study Completion Date : May 4, 2021